CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- 4 Open-market buy 10% owner bought 60,565 shares at $11.54 ($698,920)
- 4 Open-market buy Director bought 53,613 shares at $10.64 ($570,442)
- 4 Open-market buy Director bought 10,000 shares at $11.03 ($110,300)
- 4 Open-market buy Chief Financial Officer bought 37,200 shares at $10.32 ($383,904)
- 4 Open-market buy Director bought 46,387 shares at $10.37 ($481,033)
- 4 Gift Director gave 50,000 shares (gift)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Chief Financial Officer acquired 250,000 shares (option exercise)
- 4 Open-market buy Director bought 20,000 shares at $4.77 ($95,400)
- 4 Open-market buy 10% owner bought 38,000 shares at $3.44 ($130,720)
- 4 Open-market buy 10% owner bought 177,457 shares at $3.27 ($580,284)
- 4 Open-market buy Chief Financial Officer bought 42,600 shares at $3.42 ($145,692)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 8 · 143 filings